This is a Validated Antibody Database (VAD) review about pig VIM, based on 39 published articles (read how Labome selects the articles), using VIM antibody in all methods. It is aimed to help Labome visitors find the most suited VIM antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
VIM synonym: vimentin

Invitrogen
mouse monoclonal (V9)
  • western blot; human; loading ...; fig 2c
In order to investigate the effect off miR-509-5p and miR-1243 on gemcitabine efficacy in pancreatic cancer and its mechanism, Invitrogen VIM antibody (Thermo Fisher, V9) was used in western blot on human samples (fig 2c). Sci Rep (2017) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:2000; loading ...; fig 5a
In order to test if Dub3 contributes to Snail1 stability in cancer cells, Invitrogen VIM antibody (Neomarkers, Ab-2) was used in western blot on human samples at 1:2000 (fig 5a). Nat Commun (2017) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; pig; loading ...
In order to generate an enzymatic approach to isolate highly purified populations of porcine aortic endothelial and smooth muscle cells, Invitrogen VIM antibody (Thermo Fisher, MA5-11883) was used in immunocytochemistry on pig samples . J Cell Physiol (2017) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; tbl 2
In order to characterize eight cases of renal cell carcinoma cases with NONO-TFE3, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Mod Pathol (2017) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:100
In order to discuss the characteristics of Ewing's Sarcoma family of tumors of urinary bladder, Invitrogen VIM antibody (Thermo Scientific, V9) was used in immunohistochemistry on human samples at 1:100. Balkan Med J (2016) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:200; fig 1
In order to study the role of kif3a in dental mesenchymal stem and precursor cell differentiation, Invitrogen VIM antibody (Thermo Fisher, OMA1-06001) was used in immunocytochemistry on human samples at 1:200 (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (VI-01)
  • immunohistochemistry - frozen section; rat; 1:200
In order to study pregnancy in a rat model using bioengineered uterine tissue, Invitrogen VIM antibody (Thermo Scientific, MA1-19168) was used in immunohistochemistry - frozen section on rat samples at 1:200. Fertil Steril (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; rat; 1:1000; loading ...; fig 7d
In order to use electroconducting microfibers to synergistically stimulate the proliferation and migration of glial progenitor cells, Invitrogen VIM antibody (Neomarkers, MS-129) was used in immunohistochemistry on rat samples at 1:1000 (fig 7d). Acta Biomater (2016) ncbi
mouse monoclonal (V9)
  • western blot; mouse; fig 2
In order to describe a technique to measure cell mechanotype, Invitrogen VIM antibody (Thermo Scientific, MS-129-PO) was used in western blot on mouse samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (RV203)
  • western blot; human; fig 7
In order to study ectosome-mediated trafficking in fibroblasts, Invitrogen VIM antibody (Thermo, RV203) was used in western blot on human samples (fig 7). Biochim Biophys Acta (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000
In order to test if urinary fluid shear stress alters the epithelial characteristics of the renal tubule, Invitrogen VIM antibody (Neomarkers, MS-129-P) was used in western blot on human samples at 1:1000. PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • western blot; human
In order to evaluate the effect of aspirin in mesenchymal to epithelial transition, Invitrogen VIM antibody (Thermo Scientific, MS-129) was used in western blot on human samples . Lab Invest (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:150
In order to describe a 40-year-old female patient with ovarian microcystic stromal tumor and familial adenomatous polyposis, Invitrogen VIM antibody (ZYMED, V9) was used in immunohistochemistry - paraffin section on human samples at 1:150. Genes Chromosomes Cancer (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; fig s6
In order to characterize evolutionarily conserved DNA architecture which determines target specificity of the TWIST family bHLH transcription factors, Invitrogen VIM antibody (Thermo Scientific, MS-129-P) was used in western blot on human samples (fig s6). Genes Dev (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:400
In order to study the effects of dental papilla-derived human dental pulp cells on osteogenic differentiation of human dental follicle cells, Invitrogen VIM antibody (Thermo Fisher Scientific, OMA1-06001) was used in immunocytochemistry on human samples at 1:400. J Mol Histol (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; rat; 1:50; fig 7g
In order to characterize a small population of Thy1(+) mesenchymal-epithelial cells present in rat liver., Invitrogen VIM antibody (Lab Vision Corporation, MS129-PO) was used in immunocytochemistry on rat samples at 1:50 (fig 7g). Am J Pathol (2015) ncbi
mouse monoclonal (VI-10)
  • immunocytochemistry; human; 1:500
In order to optimize a spermatogonial stem cell culture system, Invitrogen VIM antibody (Pierce, VI-10) was used in immunocytochemistry on human samples at 1:500. Hum Reprod (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Hum Pathol (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen VIM antibody (Thermo Fisher Scientific, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
Invitrogen VIM antibody (Thermo, V9) was used in immunocytochemistry on human samples . Eur J Cell Biol (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:200
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry on human samples at 1:200. Histopathology (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
In order to isolate and characterize PDGFR-beta(+) perivascular cells from infantile hemangioma, Invitrogen VIM antibody (Thermo Scientific, MS-129) was used in immunocytochemistry on human samples . Int J Clin Exp Pathol (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human
  • immunocytochemistry; human
  • western blot; human; 1:1000
Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry - paraffin section on human samples , in immunocytochemistry on human samples and in western blot on human samples at 1:1000. Br J Cancer (2014) ncbi
mouse monoclonal (V9)
  • western blot; mouse; fig 3
In order to determine the difference in apparent diffusion coefficient values between epithelial- and mesenchymal-like subcutaneous mouse xenografted tumors using diffusion-weighted magnetic resonance imaging, Invitrogen VIM antibody (Thermo Scientific, MS-129-P0) was used in western blot on mouse samples (fig 3). Int J Mol Sci (2013) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (V9)
  • western blot; human
In order to study the role of TWIST1 activation by the MMSET histone methyltransferase in driving epithelial-to-mesenchymal transition and invasiveness in prostate cancer, Invitrogen VIM antibody (Thermo Scientific, MS-129) was used in western blot on human samples . Oncogene (2013) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; fig 3
In order to assess the incidence and prognostic significance of the epithelial to mesenchymal transition in cancer of unknown primary, Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry - paraffin section on human samples (fig 3). Anticancer Res (2012) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
In order to test if MSCs in hemangioma also reside in the perivascular region, Invitrogen VIM antibody (Thermo Scientific, MS-129) was used in immunocytochemistry on human samples . Pediatr Dev Pathol (2012) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:1000; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; pig; fig 7
In order to analyze the contributions of adipose tissue extract on wound healing, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on pig samples (fig 7). Wound Repair Regen (2007) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; dog; fig 2
  • western blot; human; fig 2
In order to study Goosecoid in human breast cells, Invitrogen VIM antibody (Neomarkers, MS129P) was used in immunohistochemistry on dog samples (fig 2) and in western blot on human samples (fig 2). Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:400
In order to perform a prospective study of epithelial-to-mesenchymal transition markers in biopsies obtained after engraftment from patients who received deceased donor kidneys and who had stable renal function, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry on human samples at 1:400. Am J Transplant (2006) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; rat; tbl 1
In order to characterize the tissue distribution of cytoskeletal proteins, cellular adhesion molecules, and proliferation markers in the follicular wall of letrozole-induced polycystic ovaries, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on rat samples (tbl 1). Arch Med Res (2006) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; rat
In order to compare the follicular structure and hormonal profiles of rats treated with the adrenocorticotrophic hormone with two experimental models of polycystic ovarian syndrome, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on rat samples . Physiol Res (2007) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human
  • immunohistochemistry; human
In order to report on a case of soft tissue sacrococcygeal chordoma with intracytoplasmic filamentous inclusions, Invitrogen VIM antibody (Neomarkers, V9) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry on human samples . Pathol Res Pract (2005) ncbi
mouse monoclonal (V9)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen VIM antibody (Lab Vision, MS-129-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
Articles Reviewed
  1. Hiramoto H, Muramatsu T, Ichikawa D, Tanimoto K, Yasukawa S, Otsuji E, et al. miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. Sci Rep. 2017;7:4002 pubmed publisher
  2. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  3. Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, et al. Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation. Nat Commun. 2017;8:14228 pubmed publisher
  4. Beigi F, Patel M, Morales Garza M, Winebrenner C, Gobin A, Chau E, et al. Optimized method for isolating highly purified and functional porcine aortic endothelial and smooth muscle cells. J Cell Physiol. 2017;232:3139-3145 pubmed publisher
  5. Xia Q, Wang Z, Chen N, Gan H, Teng X, Shi S, et al. Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement. Mod Pathol. 2017;30:416-426 pubmed publisher
  6. Tonyali S, Yazici S, Yeşilırmak A, Ergen A. The Ewing's Sarcoma Family of Tumors of Urinary Bladder: A Case Report and Review of the Literature. Balkan Med J. 2016;33:462-6 pubmed publisher
  7. Jiang S, Chen G, Feng L, Jiang Z, Yu M, Bao J, et al. Disruption of kif3a results in defective osteoblastic differentiation in dental mesenchymal stem/precursor cells via the Wnt signaling pathway. Mol Med Rep. 2016;14:1891-900 pubmed publisher
  8. Hellstrom M, Moreno Moya J, Bandstein S, Bom E, Akouri R, Miyazaki K, et al. Bioengineered uterine tissue supports pregnancy in a rat model. Fertil Steril. 2016;106:487-496.e1 pubmed publisher
  9. Collazos Castro J, García Rama C, Alves Sampaio A. Glial progenitor cell migration promotes CNS axon growth on functionalized electroconducting microfibers. Acta Biomater. 2016;35:42-56 pubmed publisher
  10. Qi D, Kaur Gill N, Santiskulvong C, Sifuentes J, Dorigo O, Rao J, et al. Screening cell mechanotype by parallel microfiltration. Sci Rep. 2015;5:17595 pubmed publisher
  11. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  12. Santi A, Caselli A, Ranaldi F, Paoli P, Mugnaioni C, Michelucci E, et al. Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth. Biochim Biophys Acta. 2015;1853:3211-23 pubmed publisher
  13. Maggiorani D, Dissard R, Belloy M, Saulnier Blache J, Casemayou A, Ducassé L, et al. Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells. PLoS ONE. 2015;10:e0131416 pubmed publisher
  14. Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee S. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest. 2015;95:702-17 pubmed publisher
  15. Lee S, Koh Y, Roh H, Cha H, Kwon Y. Ovarian microcystic stromal tumor: A novel extracolonic tumor in familial adenomatous polyposis. Genes Chromosomes Cancer. 2015;54:353-60 pubmed publisher
  16. Chang A, Liu Y, Ayyanathan K, Benner C, Jiang Y, Prokop J, et al. An evolutionarily conserved DNA architecture determines target specificity of the TWIST family bHLH transcription factors. Genes Dev. 2015;29:603-16 pubmed publisher
  17. Park S, Bae H, Park J. Osteogenic differentiation and gene expression profile of human dental follicle cells induced by human dental pulp cells. J Mol Histol. 2015;46:93-106 pubmed publisher
  18. Liu D, Yovchev M, Zhang J, Alfieri A, Tchaikovskaya T, Laconi E, et al. Identification and characterization of mesenchymal-epithelial progenitor-like cells in normal and injured rat liver. Am J Pathol. 2015;185:110-28 pubmed publisher
  19. Zheng Y, Thomas A, Schmidt C, Dann C. Quantitative detection of human spermatogonia for optimization of spermatogonial stem cell culture. Hum Reprod. 2014;29:2497-511 pubmed publisher
  20. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  21. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  22. García E, Machesky L, Jones G, Antón I. WIP is necessary for matrix invasion by breast cancer cells. Eur J Cell Biol. 2014;93:413-23 pubmed publisher
  23. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  24. Yuan S, Guo Y, Zhou X, Shen W, Chen H. PDGFR-? (+) perivascular cells from infantile hemangioma display the features of mesenchymal stem cells and show stronger adipogenic potential in vitro and in vivo. Int J Clin Exp Pathol. 2014;7:2861-70 pubmed
  25. Yu Y, Xiao C, Tan L, Wang Q, Li X, Feng Y. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-? signalling. Br J Cancer. 2014;110:724-32 pubmed publisher
  26. Chen Y, Pan H, Tseng H, Chu H, Hung Y, Yen Y, et al. Differentiated epithelial- and mesenchymal-like phenotypes in subcutaneous mouse xenografts using diffusion weighted-magnetic resonance imaging. Int J Mol Sci. 2013;14:21943-59 pubmed publisher
  27. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  28. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  29. Ezponda T, Popovic R, Shah M, Martinez Garcia E, Zheng Y, Min D, et al. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene. 2013;32:2882-90 pubmed publisher
  30. Stoyianni A, Goussia A, Pentheroudakis G, Siozopoulou V, Ioachim E, Krikelis D, et al. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility. Anticancer Res. 2012;32:1273-81 pubmed
  31. Yuan S, Chen R, Shen W, Chen H, Zhou X. Mesenchymal stem cells in infantile hemangioma reside in the perivascular region. Pediatr Dev Pathol. 2012;15:5-12 pubmed publisher
  32. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  33. Fu X, Fang L, Li H, Li X, Cheng B, Sheng Z. Adipose tissue extract enhances skin wound healing. Wound Repair Regen. 2007;15:540-8 pubmed
  34. Hartwell K, Muir B, Reinhardt F, Carpenter A, Sgroi D, Weinberg R. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci U S A. 2006;103:18969-74 pubmed
  35. Hertig A, Verine J, Mougenot B, Jouanneau C, Ouali N, Sebe P, et al. Risk factors for early epithelial to mesenchymal transition in renal grafts. Am J Transplant. 2006;6:2937-46 pubmed
  36. Baravalle C, Salvetti N, Mira G, Pezzone N, Ortega H. Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat. Arch Med Res. 2006;37:830-9 pubmed
  37. Baravalle C, Salvetti N, Mira G, Lorente J, Ortega H. The role of ACTH in the pathogenesis of polycystic ovarian syndrome in rats: hormonal profiles and ovarian morphology. Physiol Res. 2007;56:67-78 pubmed
  38. Guarino M, Ballabio G, Rubino B, Nebuloni M, Tosoni A. Soft tissue sacrococcygeal chordoma with intracytoplasmic filamentous inclusions. Pathol Res Pract. 2005;201:699-704 pubmed
  39. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed